rs779315456
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000222214.10(GCDH):c.937C>T(p.Arg313Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R313Q) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000222214.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCDH | NM_000159.4 | c.937C>T | p.Arg313Trp | missense_variant | 9/12 | ENST00000222214.10 | NP_000150.1 | |
GCDH | NM_013976.5 | c.937C>T | p.Arg313Trp | missense_variant | 9/12 | NP_039663.1 | ||
GCDH | NR_102316.1 | n.1100C>T | non_coding_transcript_exon_variant | 9/12 | ||||
GCDH | NR_102317.1 | n.1318C>T | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCDH | ENST00000222214.10 | c.937C>T | p.Arg313Trp | missense_variant | 9/12 | 1 | NM_000159.4 | ENSP00000222214 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249998Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135390
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1459964Hom.: 0 Cov.: 32 AF XY: 0.00000964 AC XY: 7AN XY: 726360
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1 Pathogenic:8
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 10, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 03, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 09, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 03, 2018 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The GCDH c.937C>T variant has been observed to be homozygous or in combination with another GCDH variant in several individuals affected with glutaric acidemia (Gupta et. al., 2015; Christensen et. al., 2004) This variant has been reported to affect GCDH protein function (Goodman et. al., 1998). The p.Arg313Trp variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.0008% in gnomAD database. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic. The amino acid change p.Arg313Trp in GCDH is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 313 is changed to a Trp changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. The above variant has been observed in spouse (RAJA_20400112292). - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 313 of the GCDH protein (p.Arg313Trp). This variant is present in population databases (rs779315456, gnomAD 0.006%). This missense change has been observed in individual(s) with glutaric acidemia (PMID: 15505393, 25762492, 26071121). ClinVar contains an entry for this variant (Variation ID: 379529). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GCDH protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects GCDH function (PMID: 9711871). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 17, 2024 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 04, 2022 | The c.937C>T (p.R313W) alteration is located in exon 9 (coding exon 8) of the GCDH gene. This alteration results from a C to T substitution at nucleotide position 937, causing the arginine (R) at amino acid position 313 to be replaced by a tryptophan (W). Based on data from gnomAD, the T allele has an overall frequency of <0.01% (2/249998) total alleles studied. The highest observed frequency was 0.01% (2/30616) of South Asian alleles. This variant has been reported in the homozygous and compound heterozygous states in patients with clinical and biochemical features of glutaricaciduria (Christensen, 2004; Wang, 2014; Gupta, 2015; Radha Rama Devi, 2016; Pokora, 2019). In addition, another variant at this position (p.R313Q) has also been reported in affected patients (Christensen, 2004; Wang, 2014). This amino acid position is highly conserved in available vertebrate species. In vitro studies demonstrated that this variant resulted in 0.2% residual enzyme activity when expressed in E. coli (Goodman, 1998). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 06, 2015 | The R313W missense variant has been reported previously in association withGA1 (Goodman et al.,1998 ). This variant is associated with 0.2% of normal glutaryl-CoAdehydrogenase activity when expressed in E. coli (Goodman et al., 1998). Therefore, we consider this variant to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at